These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7041940)

  • 41. Enhancement of syngeneic murine tumour transplantability by whole body irradiation--a non-immunological phenomenon.
    Peters LJ
    Br J Cancer; 1975 Mar; 31(3):293-300. PubMed ID: 1156515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential expression of class I major histocompatibility complex determinants by lymphoblastic leukemia-lymphoma cell lines.
    Hester RB; Rohrer SD; Liu PI; Coggin JH
    J Natl Cancer Inst; 1990 Jul; 82(14):1209-14. PubMed ID: 1694547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments.
    Weiss L; Reich S; Slavin S
    Cytokines Cell Mol Ther; 1999 Sep; 5(3):145-52. PubMed ID: 10641572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mixed phenotype murine leukemias.
    Defresne MP; Borremans B; Verhofstede C; Peled A; Thiry A; Greimers R; Robberecht P; Nabarra B; Verschaeve L; Hooghe R
    Leukemia; 1993 Aug; 7(8):1253-60. PubMed ID: 8350626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimal time interval between myeloablative whole body irradiation and reconstitution with syngeneic bone marrow graft.
    Weiss L; Bullorsky E; Ashkenazi YJ; Slavin S
    Bone Marrow Transplant; 1988 May; 3(3):207-10. PubMed ID: 3048487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calorie restriction reduces the incidence of radiation-induced myeloid leukaemia.
    Yoshida K; Hirabayashi Y; Inoue T
    IARC Sci Publ; 2002; 156():553-5. PubMed ID: 12484259
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus.
    Al-Ghazzouli IK; Donahoe RM; Huang KY; Sass B; Peters RL; Kelloff GJ
    J Immunol; 1976 Dec; 117(6):2239-48. PubMed ID: 186539
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The structural-functional organization of the bone marrow after lethal irradiation and the transplantation of syngeneic hematopoietic cells].
    Dygaĭ AM; Buznik DV; Shakhov VP; Gol'dberg ED
    Radiobiologiia; 1992; 32(4):575-9. PubMed ID: 1357716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Malignant myelomonocytic cells after in vitro infection of marrow cells with Friend leukaemia virus.
    Testa NG; Dexter TM; Scott D; Teich NM
    Br J Cancer; 1980 Jan; 41(1):33-9. PubMed ID: 6928787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunity as the predominant factor determining metastasis by murine lymphomas.
    Davey GC; Currie GA; Alexander P
    Br J Cancer; 1979 Oct; 40(4):590-6. PubMed ID: 497109
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug-mediated immunogenic changes of virus-induced leukemia in vivo.
    Houchens DP; Bonmassar E; Gaston MR; Kende M; Goldin A
    Cancer Res; 1976 Apr; 36(4):1347-52. PubMed ID: 1260759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro generation of cytotoxic lymphocytes against radiation- and radiation leukemia virus-induced tumors. III. Suppression of anti-tumor immunity in vitro by lymphocytes of mice undergoing radiation leukemia virus-induced leukemogenesis.
    Yefenof E; Meidav A; Kedar E
    J Exp Med; 1980 Dec; 152(6):1473-83. PubMed ID: 6256461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. H-2 typing of RBL-5, TLX/9 tumour cells and L929 fibroblast.
    Garrido F; Pérez M; Osorio C
    Rev Esp Fisiol; 1978 Jun; 34(2):137-43. PubMed ID: 694200
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leukemia-associated transplantation antigens related to murine leukemia virus. The X.1 system: immune response controlled by a locus linked to H-2.
    Sato H; Boyse EA; Aoki T; Iritani C; Old LJ
    J Exp Med; 1973 Sep; 138(3):593-606. PubMed ID: 4727915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A role for elevated H-2 antigen expression in resistance to neoplasia caused by radiation-induced leukemia virus. Enhancement of effective tumor surveillance by killer lymphocytes.
    Meruelo D
    J Exp Med; 1979 Apr; 149(4):898-909. PubMed ID: 219130
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of synergy between cyclophosphamide therapy and immunity against a mouse tumour.
    Chassoux DM; Gotch FM; MacLennan IC
    Br J Cancer; 1978 Aug; 38(2):211-8. PubMed ID: 698035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The growth patterns of two transplantable acute leukaemias of spontaneous origin in rats.
    Wrathmell AB
    Br J Cancer; 1976 Feb; 33(2):172-80. PubMed ID: 1259914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute myeloid leukemia induction in CBA/H mice by irradiation with fission neutrons as a function of exposure rate.
    Huiskamp R
    Radiat Environ Biophys; 1991; 30(3):213-5. PubMed ID: 1924708
    [No Abstract]   [Full Text] [Related]  

  • 59. [Immunostimulation of the growth of a syngeneic sarcoma primarily induced in mice by simian adenovirus SA7(C8)].
    Ageenko AI; Erkhov VS
    Vopr Onkol; 1977; 23(8):57-60. PubMed ID: 906408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Telomere-like DNA polymorphisms associated with genetic predisposition to acute myeloid leukemia in irradiated CBA mice.
    Silver A; Cox R
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1407-10. PubMed ID: 8434000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.